HJG treatment of 5/6Nx rats prevented CKD progression primarily through amelioration of inflammation through inhibition of JNK signaling in the kidney, whereas BJG exerted a protective effect against regulation of NADPH oxidase and Nrf2/HO-1 signaling. This evidence concerns the gene FMO5 and chronic kidney disease.